Rascol O - Search Results

1

A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis.

Brefel-Courbon C, Simonetta-Moreau M, Moré C, Rascol O, Clanet M, Montastruc JL, Lapeyre-Mestre M. Brefel-Courbon C, et al. Among authors: rascol o. Clin Neuropharmacol. 2000 Jul-Aug;23(4):203-7. doi: 10.1097/00002826-200007000-00006. Clin Neuropharmacol. 2000. PMID: 11020124 Clinical Trial.

2

Alopecia: an adverse effect of bromocriptine.

Fabre N, Montastruc JL, Rascol O. Fabre N, et al. Among authors: rascol o. Clin Neuropharmacol. 1993 Jun;16(3):266-8. Clin Neuropharmacol. 1993. PMID: 8504445

3

A study of salivary secretion in Parkinson's disease.

Bagheri H, Damase-Michel C, Lapeyre-Mestre M, Cismondo S, O'Connell D, Senard JM, Rascol O, Montastruc JL. Bagheri H, et al. Among authors: o connell d, rascol o. Clin Neuropharmacol. 1999 Jul-Aug;22(4):213-5. Clin Neuropharmacol. 1999. PMID: 10442250

4

Adverse drug reactions to selegiline: a review of the French pharmacovigilance database.

Montastruc JL, Chaumerliac C, Desboeuf K, Manika M, Bagheri H, Rascol O, Lapeyre-Mestre M. Montastruc JL, et al. Among authors: rascol o. Clin Neuropharmacol. 2000 Sep-Oct;23(5):271-5. doi: 10.1097/00002826-200009000-00006. Clin Neuropharmacol. 2000. PMID: 11154095 Review.

5

Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study.

Montastruc JL, Brefel-Courbon C, Senard JM, Bagheri H, Ferreira J, Rascol O, Lapeyre-Mestre M. Montastruc JL, et al. Among authors: rascol o. Clin Neuropharmacol. 2001 May-Jun;24(3):181-3. doi: 10.1097/00002826-200105000-00013. Clin Neuropharmacol. 2001. PMID: 11391132 Clinical Trial.

6

Naloxone or haloperidol but not yohimbine reverse apomorphine-induced respiratory depression.

Montastruc JL, Rascol O, Montastruc P. Montastruc JL, et al. Among authors: rascol o. Clin Neuropharmacol. 1992 Oct;15(5):404-7. doi: 10.1097/00002826-199210000-00009. Clin Neuropharmacol. 1992. PMID: 1423340

7

Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study.

Montastruc JL, Rascol O, Senard JM, Gualano V, Bagheri H, Houin G, Lees A, Rascol A. Montastruc JL, et al. Among authors: rascol a, rascol o. Clin Neuropharmacol. 1991 Oct;14(5):432-7. doi: 10.1097/00002826-199110000-00007. Clin Neuropharmacol. 1991. PMID: 1742752

8

Migraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patients.

Sabatini U, Rascol O, Rascol A, Montastruc JL. Sabatini U, et al. Among authors: rascol a, rascol o. Clin Neuropharmacol. 1990 Jun;13(3):264-7. doi: 10.1097/00002826-199006000-00011. Clin Neuropharmacol. 1990. PMID: 2357707 No abstract available.

9

A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up.

Montastruc JL, Rascol O, Rascol A. Montastruc JL, et al. Among authors: rascol a, rascol o. J Neurol Neurosurg Psychiatry. 1989 Jun;52(6):773-5. doi: 10.1136/jnnp.52.6.773. J Neurol Neurosurg Psychiatry. 1989. PMID: 2664089 Free PMC article. Clinical Trial.

10

Lack of correlation between plasma levels of amitriptyline (and nortriptyline) and clinical improvement of chronic pain of peripheral neurologic origin.

Rascol O, Tran MA, Bonnevialle P, Belin J, Cotonat J, Guiraud-Chaumeil B, Montastruc JL. Rascol O, et al. Clin Neuropharmacol. 1987 Dec;10(6):560-4. doi: 10.1097/00002826-198712000-00008. Clin Neuropharmacol. 1987. PMID: 3427563 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

595 results

Search Page

Filters